SPARCL1 and Alzheimer disease: Unexpectedly, we also observed improved cognitive outcomes in middle‐aged WT animals, which is in line with findings in humans, where SPARCL‐1 mutations are associated with poor cognitive outcomes during aging and may potentially accelerate AD onset (Seddighi et al. 2017).